Charles River Laboratories International, Inc. (NYSE:CRL) Q4 2025 Earnings Call Transcript February 18, 2026
Charles River Laboratories International, Inc. misses on earnings expectations. Reported EPS is $-5.61921 EPS, expectations were $2.33.
Operator: The Charles River Laboratories International, Inc. Fourth Quarter and Full Year 2025 Earnings Conference Call. This call is being recorded. After the speakers’ presentation, there will be a question and answer session. To ask a question...
